SCHEMBL22434751

SCHEMBL22434751

Cc1ccc(C)c2c1cc(C)n2C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALKBH5 Q6P6C2 1/20 0.42
FTO Q9C0B1 1/20 0.42
KDM4E B2RXH2 6/20 0.41
MAPT P10636 2/20 0.41
CYP1A2 P05177 4/20 0.38
CASP1 P29466 2/20 0.35
HSD17B10 Q99714 2/20 0.35
CASP7 P55210 1/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
HCRTR1 O43613 1/20 0.35
RAB9A P51151 1/20 0.35
KMT2A Q03164 1/20 0.35
DHFR P00374 1/20 0.33
NQO2 P16083 3/20 0.32
CYP2A6 P11509 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
ALDH1A1 P00352 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22434752 0.85 ALKBH5 (0.36) ALKBH5FTOKDM4EMAPTCASP1
SCHEMBL22434864 0.82 PARP15 (0.33) KDM4EMAPTCYP1A2CASP1HSD17B10
SCHEMBL22434744 0.82 CYP3A4 (0.34) KDM4EMAPTCYP1A2CASP1HSD17B10
SCHEMBL22434773 0.82 CYP19A1 (0.45) ALKBH5FTOKDM4EMAPTNPC1
SCHEMBL16382708 0.76 ALKBH5 (0.39) ALKBH5FTOKDM4EMAPTCYP1A2
SCHEMBL22729517 0.74 BRD4 (0.40) KDM4ECYP1A2NQO2CYP2C9CYP19A1
SCHEMBL16169593 0.72 CASP1 (0.32) CASP1HSD17B10CASP7DHFR
SCHEMBL20412812 0.71 ALKBH5 (0.44) ALKBH5FTOKDM4EMAPTCYP1A2
SCHEMBL20504997 0.70 ALDH1A1 (0.36) KDM4EMAPTCYP1A2HSD17B10ALDH1A1
SCHEMBL22434755 0.70 CASP1 (0.33) CASP1HSD17B10CASP7KMT2ADHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11241431-B2 N-substituted indole derivatives as PGE2 receptor modulators IDORSIA PHARMACEUTICALS LTD (CH) 2022-02-08 US disclosed
US-20200289507-A1 N-SUBSTITUTED INDOLE DERIVATIVES AS PGE2 RECEPTOR MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2020-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200289507-A1 N-SUBSTITUTED INDOLE DERIVATIVES AS PGE2 RECEPTOR MODULATORS PTGER1, PTGER4, PTGER2 ALKBH5 3212/4885FTO 4397/4885KDM4E 2755/4885
US-11241431-B2 N-substituted indole derivatives as PGE2 receptor modulators PTGER1, PTGER4, PTGER2 ALKBH5 3212/4885FTO 4397/4885KDM4E 2755/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.